by admin_camonx | Sep 13, 2019 | Uncategorized
Cambridge Oncometrix’s pivotal clinical study to validate a new test for the early detection of prostate cancer has started to recruit patients. The study is led by UCL and is conducted in three hospitals: in London (UCLH), Leeds (NHS Teaching Hospital), and Norwich...
Recent Comments